We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Choiceone Financial
COFS
$510M
| $202K | ﹤0.01% |
8,419
-320
| -4% | -$8.73K |
|
2827
DHI Group
DHX
$173M
| $201K | ﹤0.01% |
60,106
-3,470
| -5% | -$9.88K |
|
2828
First Capital
FCAP
$214M
| $201K | ﹤0.01% |
4,136
-160
| -4% | -$8.55K |
|
2829
Safe Bulkers
SB
$774M
| $200K | ﹤0.01% |
81,721
-2,520
| -3% | -$5.93K |
|
|
GFN
2830
DELISTED
General Finance Corporation
GFN
| $200K | ﹤0.01% |
16,462
-580
| -3% | -$5.87K |
|
2831
Corbus Pharmaceuticals
CRBP
$190M
| $199K | ﹤0.01% |
3,363
-67
| -2% | -$4.4K |
|
2832
Assembly Biosciences
ASMB
$529M
| $198K | ﹤0.01% |
3,593
-232
| -6% | -$15.4K |
|
2833
Westwood Holdings Group
WHG
$190M
| $198K | ﹤0.01% |
13,714
-270
| -2% | -$4.13K |
|
|
TIG
2834
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $198K | ﹤0.01% |
12,256
-580
| -5% | -$9.27K |
|
2835
Ovid Therapeutics
OVID
$491M
| $197K | ﹤0.01% |
48,990
-680
| -1% | -$2.26K |
|
|
MRLN
2836
DELISTED
Marlin Business Services Corp
MRLN
| $197K | ﹤0.01% |
14,447
-1,600
| -10% | -$22.2K |
|
|
ALSK
2837
DELISTED
Alaska Communications Systems
ALSK
| $196K | ﹤0.01% |
60,412
-2,460
| -4% | -$8.07K |
|
2838
Gencor Industries
GENC
$212M
| $194K | ﹤0.01% |
14,487
+25
| +0.2% | +$336 |
|
2839
Solid Biosciences
SLDB
$900M
| $194K | ﹤0.01% |
2,337
+4
| +0.2% | +$443 |
|
2840
Hamilton Beach Brands
HBB
$422M
| $193K | ﹤0.01% |
10,667
-360
| -3% | -$6.54K |
|
|
CSPR
2841
DELISTED
Casper Sleep Inc.
CSPR
| $192K | ﹤0.01% |
26,582
-1,370
| -5% | -$11.1K |
|
2842
Fortress Biotech
FBIO
$88.7M
| $189K | ﹤0.01% |
3,563
+32
| +0.9% | +$1.8K |
|
2843
Oak Valley Bancorp
OVLY
$281M
| $189K | ﹤0.01% |
11,037
| – | – |
|
2844
Xeris Biopharma Holdings
XERS
$1.45B
| $188K | ﹤0.01% |
41,774
-1,426
| -3% | -$7.69K |
|
|
IVAC
2845
DELISTED
Intevac Inc
IVAC
| $188K | ﹤0.01% |
26,331
+475
| +2% | +$3.17K |
|
|
PBIP
2846
DELISTED
Prudential Bancorp, Inc.
PBIP
| $188K | ﹤0.01% |
12,738
-1,210
| -9% | -$16.3K |
|
2847
NextCure
NXTC
$26.7M
| $187K | ﹤0.01% |
1,555
-67
| -4% | -$9.7K |
|
2848
Legacy Housing
LEGH
$694M
| $186K | ﹤0.01% |
10,512
-460
| -4% | -$7.34K |
|
|
TCDA
2849
DELISTED
Tricida, Inc. Common Stock
TCDA
| $186K | ﹤0.01% |
35,230
-3,370
| -9% | -$21.2K |
|
2850
Richmond Mutual Bancorp
RMBI
$254M
| $185K | ﹤0.01% |
13,637
-660
| -5% | -$8.89K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.